Popular, Life Sciences, Investors

Insights From the 21st Annual McGuireWoods Healthcare Private Equity and Finance Conference: Part 1

McGuireWoods LLP on 5/21/2025

McGuireWoods held its 21st Annual Healthcare Private Equity and Finance Conference in Chicago, May 13-15, 2025. This premier conference brought together leading healthcare investors, lenders, executives, consultants and...more

Life Sciences Under the Microscope: Key 2024 Takeaways and What’s Ahead for 2025

Ropes & Gray LLP on 2/28/2025

The life sciences industry experienced a dynamic year in 2024. As the public markets gained traction, IPO activity and venture investment saw a resurgence, signaling renewed investor confidence and reflecting sustained...more

The State of the Funding Market for AI Companies: A 2024 - 2025 Outlook

Mintz Edge on 2/19/2025

Artificial intelligence (AI) has emerged as an influential technology, driving notable investments across various industries in recent years. In 2024, venture capital (VC) funding for AI companies reached record levels,...more

2025 Perspectives in Private Equity: Health Care & Life Sciences

Akin Gump Strauss Hauer & Feld LLP on 2/13/2025

Private equity investors in health care and life sciences must navigate a complex and shifting landscape influenced by regulatory and policy changes and technological advancements. As private equity investments in the health...more

Healthcare & Life Sciences Private Equity Deal Tracker: New Mountain to Acquire Machinify

McGuireWoods LLP on 1/16/2025

New Mountain Capital has announced it will acquire Machinify. Machinify, founded in 2016 and based in Palo Alto, California, is a provider of artificial intelligence (AI)-powered software focused on healthcare claims and...more

Quarterly Healthcare Transactions Review: Unveiling the Latest Industry Mergers and Acquisitions [Q1 2024]

Ankura on 7/18/2024

Ankura is pleased to present an overview of healthcare transactions announced or closed during Q1 2024 in the United States. Total transactions decreased by 7.6% in the first quarter of 2024 after remaining relatively flat in...more

Healthcare Trends & Transactions Q2 2023

Bass, Berry & Sims PLC on 7/28/2023

The healthcare M&A market appears to be steadying. Although deal activity through the year appears slightly below the high-water marks for the corresponding period of 2022, deal activity is generally up from the first quarter...more

ESG Insights: Silicon Valley’s Largest Public Tech and Life Sciences Companies Stepped Up ESG Reporting Last Year

Fenwick & West LLP on 4/5/2023

Environmental, social and governance (ESG) concerns and how companies respond to them continue to generate scrutiny from a large number of stakeholders. Last year, in our ESG in Silicon Valley: A Look at the ESG Disclosure...more

Inside the Courts – An Update From Skadden Securities Litigators - March 2023

Skadden, Arps, Slate, Meagher & Flom LLP on 3/16/2023

Circuits Split Over Whether Targeting Is Necessary for Seller Liability - Key Points - - While courts have long held that solicitations must be tailored to a particular audience to precipitate statutory seller liability,...more

Life Sciences Real Estate Update -1.06.23 #1

Allen Matkins on 1/9/2023

California’s lab and biotech industries provide 435,693 jobs that generate $376 billion in total economic output, according to a new report from Biocom California, an association representing life sciences companies and...more

[Event] 2023 J.P. Morgan Healthcare Conference - January 10th, San Francisco, CA

McDermott Will & Schulte on 1/5/2023

Come together with key decision-makers, innovators and investors from across the healthcare, life sciences and private equity (PE) industries during the year’s largest healthcare investment symposium....more

Life Sciences Real Estate Update - October 2022

Allen Matkins on 10/10/2022

Newmark: U.S. life sciences investment dips but main hubs dodge headwinds - Commercial Observer – September 29 - Overall investment in the national life sciences market is shrinking, but the drop in venture capital funding...more

Healthcare Transactions Q1 2022

Bass, Berry & Sims PLC on 4/15/2022

2022 started strong for healthcare transactions with some reports suggesting a record-breaking January. Although deal activity cooled in February and March, transaction pipelines still indicate that 2022 is on pace to match...more

European Life Sciences Deals Trends

Goodwin on 4/13/2022

In Europe, life sciences deals increased over the last few years with strong acceleration in 2021. As a result, the market wonders whether this is just an uptick or rather a steady trend which will impact our market in the...more

[Event] 2022 Life Sciences Dealmaking Symposium & Investment Forum - April 28th - 29th, Boston, MA

McDermott Will & Schulte on 3/28/2022

At the Life Sciences Dealmaking Symposium and Investment Forum, seasoned dealmakers, investors industry executives and technical experts will join McDermott's leading transactional, venture financing and private equity...more

Navigating the New Normal: Adaptive Reuse of Space

Goodwin on 6/8/2021

When you think of adaptive reuse, you likely associate it with turning a rustic barn, an old-time firehouse or former chapel into a cottage, modern loft or chic house. More broadly, however, adaptive reuse is any redesign,...more

Propsci – An Underestimated Real Estate Asset Class In Germany

Goodwin on 12/8/2020

World affairs are currently clouded by the global COVID-19 pandemic. In a very short period of time, approximately 191 vaccine projects have been launched according to the World Health Organization (WHO). Among the countries...more

Global Trends and Opportunities in Life Sciences Real Estate – Spotlighting the U.S. and the UK

Goodwin on 9/30/2020

An aging global population, a once-in-a-century pandemic and the continued convergence of scientific breakthroughs like cell and gene therapies and artificial intelligence are among just a few of the key factors that continue...more

Vital Signs: Digital Health Law Update | Summer 2020

Jones Day on 7/21/2020

Note From the Editors - With this Summer 2020 issue of Vital Signs, we take a moment to again applaud the remarkable actions of all the health care and life science organizations around the globe working tirelessly on our...more

Healthcare & Life Sciences Private Equity Deal Tracker: Veritas Capital to Acquire DXC Technology Healthcare Unit for $5 Billion

McGuireWoods LLP on 3/13/2020

DXC Technology has announced it will sell its healthcare technology business to Veritas Capital....more

Today's Popular Updates › Life Sciences › Investors